Zuari Industries Q1 FY26: Beyond the Standalone – Unpacking the Turnaround & Debt Play

Zuari Industries’ Q1 FY26 earnings hide a fascinating turnaround story. While standalone …

Aug 21, 2025 02:26

Medicamen Biotech Q1 FY26: Profits Plummet, But One Key Number Soars. What's Driving MBIL's Mixed Fortunes?

Medicamen Biotech’s Q1 FY26 results are in, revealing a complex financial picture. While …

Aug 15, 2025 01:22